<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1F394169-7A00-4261-9FDA-895511475F77"><gtr:id>1F394169-7A00-4261-9FDA-895511475F77</gtr:id><gtr:name>Axordia Limited</gtr:name><gtr:address><gtr:line1>INNOVATION HOUSE , CREWE ROAD</gtr:line1><gtr:city>MANCHESTER</gtr:city><gtr:postCode>M23 9QR</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1F394169-7A00-4261-9FDA-895511475F77" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>1F394169-7A00-4261-9FDA-895511475F77</gtr:id><gtr:name>Axordia Limited</gtr:name><gtr:address><gtr:line1>INNOVATION HOUSE , CREWE ROAD</gtr:line1><gtr:city>MANCHESTER</gtr:city><gtr:postCode>M23 9QR</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>71585.0</gtr:offerGrant><gtr:projectCost>529132.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0C814A2C-0DB0-4F83-A00A-B1D2AC0F8B57" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>0C814A2C-0DB0-4F83-A00A-B1D2AC0F8B57</gtr:id><gtr:name>Lombard Limited</gtr:name><gtr:address><gtr:line1>277 GRAY'S INN ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>WC1X 8QF</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>63436.0</gtr:offerGrant><gtr:projectCost>468742.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>390732.0</gtr:offerGrant><gtr:projectCost>390732.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=100048"><gtr:id>6D65BF71-3FA5-448D-A1F6-C8B7FAB3BB68</gtr:id><gtr:title>regenative Stants to treat cardiovas. Disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>100048</gtr:grantReference><gtr:abstractText>Cardiovascular disease (CVD) is the most serious health concern facing the UK. Stents have been one of the most important advances in the treatment of CVD, but restenosis (inflammatory thickening of artery caused by the stent) and late thrombosis are major problems. This project will provide crucial platform technologies and develop a new benchmark in stent technology. Applied science research will create a surface-modified stent with a bioactive cellular scaffold coat - a novel regenerative implant that promotes vascular repair. Stem cell-derived, non- GM, endovascular cells that provide a localised immune privileged site and controlled vascular repair combined with a programmable polymer coronary stent surface coating will give a targeted delivery system. Industry ready platform technologies will be developed that can also support other cell-based regenerative therapeutics, cell delivery systems, scaffolds, in vivo modelling and GMP production.</gtr:abstractText><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2006-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>900582</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">100048</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>